Mirabaud Asset Management Ltd Decreases Holdings in The Clorox Company $CLX

Mirabaud Asset Management Ltd trimmed its position in shares of The Clorox Company (NYSE:CLX) by 61.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,511 shares of the company’s stock after selling 8,742 shares during the quarter. Mirabaud Asset Management Ltd’s holdings in Clorox were worth $657,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Horizon Investments LLC lifted its holdings in Clorox by 4.4% in the first quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock valued at $258,000 after acquiring an additional 75 shares during the period. Sfmg LLC grew its stake in shares of Clorox by 2.8% during the 1st quarter. Sfmg LLC now owns 2,780 shares of the company’s stock valued at $409,000 after purchasing an additional 76 shares during the period. Hancock Whitney Corp increased its position in shares of Clorox by 4.3% during the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock valued at $304,000 after purchasing an additional 86 shares during the last quarter. Brown Lisle Cummings Inc. increased its position in shares of Clorox by 4.3% during the 2nd quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares during the last quarter. Finally, American National Bank & Trust lifted its stake in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.0%

Shares of CLX stock opened at $107.37 on Friday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a one year low of $106.14 and a one year high of $171.37. The company’s fifty day moving average price is $119.49 and its 200-day moving average price is $124.82. The company has a market capitalization of $13.10 billion, a price-to-earnings ratio of 16.47, a PEG ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the firm posted $1.86 EPS. Clorox’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd were given a dividend of $1.24 per share. The ex-dividend date was Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.6%. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CLX. Deutsche Bank Aktiengesellschaft cut their target price on shares of Clorox from $128.00 to $121.00 and set a “hold” rating for the company in a research report on Tuesday, November 4th. Wells Fargo & Company dropped their price target on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Rothschild & Co Redburn cut their price objective on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research report on Wednesday. Citigroup reduced their price objective on Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a research note on Tuesday, November 4th. Finally, BNP Paribas Exane decreased their target price on Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a report on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $125.69.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.